Overview
US Stock Market
Technology
Financial
Real Estate
Energy
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Healthcare
Industrials
Utilities
Other Symbols
Currencies
Major
Minor
America
Europe
Asia
Cryptocurrencies
Metals
Indexes
Commodities
Charts
WidgetsSMMT: Summit Therapeutics Inc
SMMT exchange rate has changed by -3.22% for today. During the day, the instrument was traded at a low of 15.13 and at a high of 15.70.
Follow Summit Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
SMMT News
- Can Expanding Ivonescimab Development Unlock SMMT's Growth Potential?
- Summit Therapeutics Announces Clinical Trial Collaboration With The ECOG-ACRIN Cancer Research Group To Evaluate Ivonescimab In A Phase II/III Study In Biliary Tract Cancer
- Summit Therapeutics Announced Opening Of Global Phase II SMT112-216 Trial Of Ivonescimab Alone Or Combined With Cadonilimab Or Ipilimumab In Previously Untreated Advanced Clear Cell Renal Cell Carcinoma,
- Chip Stocks Slide as South Korea's KOSPI Plunges, J&J Sinks 6%: Stock Market Today
- 10 Health Care Stocks With Whale Alerts In Today’s Session
- Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%
- Amazon, Alphabet, Tesla Stock Rises: Robinhood Traders Sell Anyway
- SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway Combos
- Summit Therapeutics Announces Closing Of AstraZeneca's $2B Convertible Preferred Investment, Equivalent To $18.36/Share Of Common Stock
- BioNTech SE: Moving Past Covid (NASDAQ:BNTX)
- AstraZeneca, Daiichi Sankyo Expand Cancer Push Through Summit Partnership
- Summit Therapeutics, AstraZeneca And Daiichi Sankyo Announce Clinical Trial Collaboration To Evaluate Ivonescimab With TROP2-Directed ADC Datroway Across Multiple Tumor Types, Starting With Phase III First-Line Triple-Negative Breast Cancer Study
- Robinhood Traders Just Went on Their Biggest Buying Binge Ever
- Barclays Maintains Equal-Weight on Summit Therapeutics, Raises Price Target to $20
- Summit Therapeutics Stock Climbs Wednesday: What's Happening?
- Nasdaq 100 Climbs as Cooler PCE Cuts Rate Hike Bets, Micron Earnings Loom: Stock Market Today
- Stocks Settle Mixed as Bond Yields Rise
- A $2 Billion Reason Why AstraZeneca Stock Is Down Today
- Citigroup Maintains Buy on Summit Therapeutics, Raises Price Target to $43
- Summit Shares Jump on $2B Strategic Investment From AstraZeneca
- Stocks Turn Mixed as Bond Yields Rise
- Stocks Rebound as Crude Prices Fall and Bond Yields Stabilize
- AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck
- AstraZeneca Invests in Summit Therapeutics after Year of Speculation
Frequently Asked Questions
What is SMMT stock price today?
Summit Therapeutics Inc stock is priced at 15.32 today. It trades within 15.13 - 15.70, yesterday's close was 15.83, and trading volume reached 1552. The live price chart of SMMT shows these updates.
Does Summit Therapeutics Inc stock pay dividends?
Summit Therapeutics Inc is currently valued at 15.32. Dividend policy depends on the company, while investors also watch -18.75% and USD. View the chart live to track SMMT movements.
How to buy SMMT stock?
You can buy Summit Therapeutics Inc shares at the current price of 15.32. Orders are usually placed near 15.32 or 15.62, while 1552 and 0.20% show market activity. Follow SMMT updates on the live chart today.
How to invest into SMMT stock?
Investing in Summit Therapeutics Inc involves considering the yearly range 12.07 - 29.23 and current price 15.32. Many compare -8.92% and -4.37% before placing orders at 15.32 or 15.62. Explore the SMMT price chart live with daily changes.
What are Summit Therapeutics Inc stock highest prices?
The highest price of Summit Therapeutics Inc in the past year was 29.23. Within 12.07 - 29.23, the stock fluctuated notably, and comparing with 15.83 helps spot resistance levels. Track Summit Therapeutics Inc performance using the live chart.
What are Summit Therapeutics Inc stock lowest prices?
The lowest price of Summit Therapeutics Inc (SMMT) over the year was 12.07. Comparing it with the current 15.32 and 12.07 - 29.23 shows potential long-term entry points. Watch SMMT moves on the chart live for more details.
When did SMMT stock split?
Summit Therapeutics Inc has gone through stock splits historically. These changes are visible in , 15.83, and -18.75% after corporate actions.
- Previous Close
- 15.83
- Open
- 15.29
- Bid
- 15.32
- Ask
- 15.62
- Low
- 15.13
- High
- 15.70
- Volume
- 1.552 K
- Daily Change
- -3.22%
- Month Change
- -8.92%
- 6 Months Change
- -4.37%
- Year Change
- -18.75%
- Act
- 194 K
- Fcst
- 198 K
- Prev
- 200 K
- Act
- 1.728 M
- Fcst
- 1.723 M
- Prev
- 1.703 M
- Act
- 0.0%
- Fcst
- 0.0%
- Prev
- -0.1%
- Act
- Fcst
- Prev
- 1.955%